Clal Biotechnology Industries Ltd (CBI) — Working Capital to Net Assets Ratio
Clal Biotechnology Industries Ltd (CBI) has a Working Capital to Net Assets ratio of -49.0% as of June 2025. Working capital of ILA-15.98 Million (current assets of ILA2.07 Million minus current liabilities of ILA18.05 Million) is measured against net assets of ILA32.60 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Clal Biotechnology Industries Ltd (CBI) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Clal Biotechnology Industries Ltd Working Capital to Net Assets (2006–2024)
This chart shows how Clal Biotechnology Industries Ltd's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2006 to 2024. As of June 2025, the ratio stands at -49.0%, reflecting working capital of ILA-15.98 Million against net assets of ILA32.60 Million ILA. Check Clal Biotechnology Industries Ltd (CBI) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Clal Biotechnology Industries Ltd (2006–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Clal Biotechnology Industries Ltd from 2006 to 2024, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see CBI company net worth.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -30.8% | ILA-14.20 Million | ILA46.16 Million | ILA5.80 Million | ILA20.00 Million | ▼ -37.4 pp |
| 2023 | 6.6% | ILA8.03 Million | ILA121.41 Million | ILA14.69 Million | ILA6.66 Million | ▼ -2.9 pp |
| 2022 | 9.5% | ILA13.73 Million | ILA144.90 Million | ILA16.64 Million | ILA2.91 Million | ▼ -2.9 pp |
| 2021 | 12.4% | ILA41.96 Million | ILA338.37 Million | ILA77.61 Million | ILA35.65 Million | ▼ -23.2 pp |
| 2020 | 35.6% | ILA182.81 Million | ILA513.79 Million | ILA211.09 Million | ILA28.28 Million | ▲ +16.2 pp |
| 2019 | 19.3% | ILA96.30 Million | ILA497.85 Million | ILA137.35 Million | ILA41.05 Million | ▲ +6.0 pp |
| 2018 | 13.3% | ILA115.43 Million | ILA867.62 Million | ILA139.11 Million | ILA23.68 Million | ▼ -5.8 pp |
| 2017 | 19.1% | ILA154.05 Million | ILA808.20 Million | ILA185.23 Million | ILA31.18 Million | ▲ +2.7 pp |
| 2016 | 16.4% | ILA123.07 Million | ILA752.50 Million | ILA191.35 Million | ILA68.28 Million | ▼ -5.7 pp |
| 2015 | 22.0% | ILA240.86 Million | ILA1.09 Billion | ILA307.64 Million | ILA66.78 Million | ▼ -8.4 pp |
| 2014 | 30.4% | ILA382.98 Million | ILA1.26 Billion | ILA446.39 Million | ILA63.41 Million | ▲ +20.7 pp |
| 2013 | 9.7% | ILA133.99 Million | ILA1.38 Billion | ILA184.96 Million | ILA50.97 Million | ▼ -1.6 pp |
| 2012 | 11.3% | ILA157.94 Million | ILA1.40 Billion | ILA202.37 Million | ILA44.42 Million | ▼ -7.5 pp |
| 2011 | 18.8% | ILA208.74 Million | ILA1.11 Billion | ILA243.37 Million | ILA34.63 Million | ▲ +1.4 pp |
| 2010 | 17.4% | ILA213.82 Million | ILA1.23 Billion | ILA236.67 Million | ILA22.85 Million | ▼ -19.5 pp |
| 2009 | 36.9% | ILA289.13 Million | ILA782.91 Million | ILA308.46 Million | ILA19.34 Million | ▼ -33.8 pp |
| 2008 | 70.7% | ILA194.06 Million | ILA274.45 Million | ILA254.96 Million | ILA60.90 Million | ▼ -20.3 pp |
| 2007 | 91.0% | ILA281.75 Million | ILA309.49 Million | ILA294.05 Million | ILA12.30 Million | ▲ +56.6 pp |
| 2006 | 34.5% | ILA40.06 Million | ILA116.28 Million | ILA43.43 Million | ILA3.37 Million | — |